Global Contract Pharmaceutical Manufacturing Market Report, forecast to 2022


  • Summary
    Contract Pharmaceutical Manufacturing refers to accept commissioned from pharmaceutical companies, provide the service about API production, agent production, packaging and son on which required for pharmaceutical manufacturing.
    The global Contract Pharmaceutical Manufacturing market will reach xxx Million USD in 2017. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
    ???
    Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
    Active Pharmaceutical Ingredients
    Finished Dosage Formulations
    Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
    Catalent
    DPx
    Lonza
    Piramal Healthcare
    Aenova
    Jubilant
    Famar
    Boehringer Ingelheim
    Fareva Holding
    AbbVie
    Nipro Corp
    Vetter
    Sopharma
    DPT Laboratories
    Recipharm
    NextPharma
    Dishman
    Aesica
    Based on Application, the report describes major application share of regional market. Application mentioned as follows:
    Generics
    Big Pharma
    Other
    Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa

  • Table of Contents
    1 Market Overview
    1.1 Objectives of Research
    1.1.1 Definition
    1.1.2 Specifications
    1.2 Market Segment
    1.2.1 Upstream
    1.2.2 Downstream
    1.2 Market Segment
    1.2.1 by Type
    1.2.1.1 Active Pharmaceutical Ingredients
    1.2.1.2 Finished Dosage Formulations
    1.2.2 by Application
    1.2.2.1 Generics
    1.2.2.2 Big Pharma
    1.2.2.3 Other
    1.2.3 by Regions
    2 Industry Chain
    2.1 Industry Chain Structure
    2.2 Upstream
    2.3 Market
    2.3.1 SWOT
    2.3.2 Dynamics
    3 Environmental Analysis
    3.1 Policy
    3.2 Economic
    3.3 Technology
    3.4 Market Entry
    4 Market Segmentation by Type
    4.1 Market Size
    4.1.1 Active Pharmaceutical Ingredients Market, 2011-2016
    4.1.2 Finished Dosage Formulations Market, 2011-2016
    4.2 Market Forecast
    4.2.1 Active Pharmaceutical Ingredients Market Forecast, 2017-2022
    4.2.2 Finished Dosage Formulations Market Forecast, 2017-2022
    5 Market Segmentation by Application
    5.1 Market Size
    5.1.1 Generics Market, 2011-2016
    5.1.2 Big Pharma Market, 2011-2016
    5.1.3 Other Market, 2011-2016
    5.2 Market Forecast
    5.2.1 Generics Market Forecast, 2017-2022
    5.2.2 Big Pharma Market Forecast, 2017-2022
    5.2.3 Other Market Forecast, 2017-2022
    6 Market Segmentation by Region
    6.1 Market Size
    6.1.1 Asia-Pacific
    6.1.1.1 Asia-Pacific Market, 2011-2016
    6.1.1.2 Asia-Pacific Market by Type
    6.1.1.3 Asia-Pacific Market by Application
    6.1.2 North America
    6.1.2.1 North America Market, 2011-2016
    6.1.2.2 North America Market by Type
    6.1.2.3 North America Market by Application
    6.1.3 Europe
    6.1.3.1 Europe Market, 2011-2016
    6.1.3.2 Europe Market by Type
    6.1.3.3 Europe Market by Application
    6.1.4 South America
    6.1.4.1 South America Market, 2011-2016
    6.1.4.2 South America Market by Type
    6.1.4.3 South America Market by Application
    6.1.5 Middle East & Africa
    6.1.5.1 Middle East & Africa Market, 2011-2016
    6.1.5.2 Middle East & Africa Market by Type
    6.1.5.3 Middle East & Africa Market by Application
    6.2 Market Forecast
    6.2.1 Asia-Pacific Market Forecast, 2017-2022
    6.2.2 North America Market Forecast, 2017-2022
    6.2.3 Europe Market Forecast, 2017-2022
    6.2.4 South America Market Forecast, 2017-2022
    6.2.5 Middle East & Africa Market Forecast, 2017-2022
    7 Market Competitive
    7.1 Global Market by Vendors
    7.2 Market Concentration
    7.3 Price & Factors
    7.4 Marketing Channel
    8 Major Vendors
    8.1 Catalent
    8.1.2 Profile
    8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.2 DPx
    8.2.1 Profile
    8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.3 Lonza
    8.3.1 Profile
    8.3.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.4 Piramal Healthcare
    8.4.1 Profile
    8.4.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.5 Aenova
    8.5.1 Profile
    8.5.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.6 Jubilant
    8.6.1 Profile
    8.6.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.7 Famar
    8.7.1 Profile
    8.7.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.8 Boehringer Ingelheim
    8.8.1 Profile
    8.8.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.9 Fareva Holding
    8.9.1 Profile
    8.9.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.10 AbbVie
    8.10.1 Profile
    8.10.2 Business Performance (Sales Revenue, Cost, Gross Margin)
    8.11 Nipro Corp
    8.12 Vetter
    8.13 Sopharma
    8.14 DPT Laboratories
    8.15 Recipharm
    8.16 NextPharma
    8.17 Dishman
    8.18 Aesica
    9 Conclusion

  • Inquiry Before Buying

    Your Name (required)

    Your Email (required)

    Telephone Number (required)

    Name of Company (required)

    Designation (required)

    Country Name (required)

    How can we help you?

    Prove You are Human (required)

    captcha
    Enter Capcha Image Properly

  • Your Name (required)

    Your Email (required)

    Telephone Number (required)

    Name of Company (required)

    Designation (required)

    Country Name (required)

    How can we help you?

    Prove You are Human (required)

    captcha
    Enter Capcha Image Properly